InvestorsHub Logo

H2R

Followers 42
Posts 2184
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: ConstitutionNow post# 10855

Thursday, 11/02/2017 4:38:41 PM

Thursday, November 02, 2017 4:38:41 PM

Post# of 12137
Cryoport Revenue Up 52%; Driven by BioPharma

https://seekingalpha.com/pr/16990079-cryoport-revenue-52-percent-driven-biopharma

We are now supporting a record-breaking 195 clinical trials, with 23 new clinical trials secured in the third quarter, driving a 65% year-over-year revenue increase in our lead market, the biopharma market. We are proud of the significant traction we have made in supporting our client's clinical trials. We believe that this activity is the just the 'tip of the iceberg' as our biopharma market revenue is expected to significantly ramp as our clients' regenerative therapies reach commercial viability, requiring more extensive logistics support from Cryoport.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News